[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Johnson & Johnson: Can the Pipeline Actually Replace What Stelara Was?

Johnson & Johnson reports second-quarter earnings before the bell on July 15, with Wall Street watching whether the healthcare giant can sustain its recent momentum amid a volatile geopolitical backdrop. The central question is whether JNJ can deliver on elevated expectations—consensus now calls for $2.85 per share, up from prior estimates—while navigating supply chain pressures and currency headwinds stemming from the escalating U.S.-Iran conflict and oil price volatility. With the stock trading near recent highs and analyst sentiment firmly bullish, any disappointment could trigger an outsized reaction.

Johnson & Johnson is a diversified healthcare conglomerate operating across three main...

Fundamentals

See More
  • Market Capitalization, $K 620,508,288
  • Shares Outstanding, K 2,407,217
  • Annual Sales, $ 94,193 M
  • Annual Income, $ 26,804 M
  • EBIT $ 23,115 M
  • EBITDA $ 30,618 M
  • 60-Month Beta 0.24
  • Price/Sales 6.57
  • Price/Cash Flow 18.20
  • Price/Book 7.62

Options Overview Details

View History
  • Implied Volatility 27.30% (+0.02%)
  • Historical Volatility 27.39%
  • IV Percentile 91%
  • IV Rank 81.23%
  • IV High 30.74% on 07/07/26
  • IV Low 12.42% on 07/24/25
  • Expected Move (DTE 2) 7.02 (2.77%)
  • Put/Call Vol Ratio 0.93
  • Today's Volume 31,265
  • Volume Avg (30-Day) 28,468
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 391,195
  • Open Int (30-Day) 370,945
  • Expected Range 246.83 to 260.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.85
  • Number of Estimates 7
  • High Estimate $2.91
  • Low Estimate $2.69
  • Prior Year $2.77
  • Growth Rate Est. (year over year) +2.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
227.50 +11.58%
on 06/22/26
269.43 -5.78%
on 07/07/26
+12.98 (+5.39%)
since 06/12/26
3-Month
220.37 +15.19%
on 05/11/26
269.43 -5.78%
on 07/07/26
+13.75 (+5.73%)
since 04/14/26
52-Week
154.80 +63.99%
on 07/15/25
269.43 -5.78%
on 07/07/26
+97.03 (+61.87%)
since 07/14/25

Most Recent Stories

More News
Johnson & Johnson: Can the Pipeline Actually Replace What Stelara Was?

Barchart Research What to Expect from JNJ Earnings JNJ Generated July 14, 2026 Current Price $253.85 EPS Estimate $$2.85 Consensus Rating Moderate Buy Average Move 1.86% Johnson & Johnson: Can the Pipeline...

JNJ : 253.85 (-1.52%)
Stocks Set to Open Lower as SK Hynix Sparks Chip Selloff, U.S. Inflation Data and Big Bank Earnings Awaited

September S&P 500 E-Mini futures (ESU26) are down -0.29%, and September Nasdaq 100 E-Mini futures (NQU26) are down -0.94% this morning, pointing to a lower open on Wall Street as chipmakers came under...

BLK : 1,025.44 (-0.59%)
C : 133.27 (-5.29%)
SNDK : 1,757.82 (+5.01%)
JPM : 342.89 (+2.50%)
NQU26 : 30,022.00 (+0.78%)
JNJ : 253.85 (-1.52%)
UNH : 425.19 (-0.91%)
ELV : 426.79 (+0.38%)
ABT : 88.96 (-3.42%)
WFC : 85.29 (-2.71%)
ESU26 : 7,605.00 (+0.18%)
BBY : 83.98 (+2.85%)
New Fed Boss Speaks Next Week

Monday U.S. Economic Lookahead Monthly U.S. federal budget (June) Featured Earnings ...

BAC : 60.62 (+1.88%)
MS : 227.67 (+2.98%)
JNJ : 253.85 (-1.52%)
HDB : 25.97 (-1.67%)
GLDG : 0.8500 (+0.70%)
GS : 1,140.00 (+9.00%)
MMM : 156.58 (-0.71%)
FBK : 58.40 (+3.23%)
UNH : 425.19 (-0.91%)
ASML : 1,775.64 (+2.87%)
TSM : 420.39 (-0.28%)
IBN : 29.00 (-0.89%)
Huge Earnings, Inflation Data and Other Key Things to Watch this Week

Markets face one of the year's most important weeks as Federal Reserve Chair Kevin Warsh delivers his inaugural semi-annual monetary policy testimony before Congress on July 14 and 15.

NFLX : 73.53 (-0.41%)
UAL : 120.35 (-0.67%)
C : 133.27 (-5.29%)
BAC : 60.62 (+1.88%)
JPM : 342.89 (+2.50%)
MS : 227.67 (+2.98%)
JNJ : 253.85 (-1.52%)
GS : 1,140.00 (+9.00%)
UNH : 425.19 (-0.91%)
TSM : 420.39 (-0.28%)
ASML : 1,775.64 (+2.87%)
WFC : 85.29 (-2.71%)
This Dividend ETF Choice Could Shape Your Income Strategy Through 2026

VYM and SCHD both offer low-cost dividend exposure, but differ in methodology, yield, and holdings—VYM emphasizes broad, higher-yield diversification, while SCHD focuses on stricter, dividend-growth...

MO : 70.16 (-2.38%)
AVGO : 389.11 (+1.32%)
KO : 83.08 (-1.39%)
JPM : 342.89 (+2.50%)
XOM : 145.09 (+0.40%)
JNJ : 253.85 (-1.52%)
PG : 146.08 (-1.54%)
SCHD : 32.20 (-1.11%)
PEP : 135.45 (-2.20%)
VYM : 160.18 (-0.42%)
TXN : 305.55 (+2.34%)
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger

As Middle East tensions resurface and futures drop, VIG, VIGI, and FDVV offer dividend growth ETFs combining income with exposure to technology and global equities.

NVDA : 211.80 (+4.06%)
AAPL : 314.86 (-0.77%)
AVGO : 389.11 (+1.32%)
SAP : 154.81 (-3.23%)
JNJ : 253.85 (-1.52%)
RY : 214.04 (+1.59%)
NVS : 150.36 (-1.96%)
RHHBY : 50.1600 (-0.67%)
NSRGY : 103.2200 (-0.15%)
SBGSY : 61.9000 (+2.30%)
MSFT : 384.93 (-1.55%)
VIG : 237.30 (-0.49%)
Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Dual Energy THERMOCOOL SMARTTOUCH SF Platform brings pulse field and radiofrequency energy together in a single catheter. ...

JNJ : 253.85 (-1.52%)
Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup

Today, there has been large and unusual put option activity in Johnson & Johnson (JNJ) after the stock's recent rise. The puts are out-of-the-money (OTM), implying that some investors believe JNJ could...

JNJ : 253.85 (-1.52%)
Only 3 Under-the-Radar Dividend Stocks Survived This Brutal Screen. One Could Rally 115%.

Three under-the-radar dividend stocks with solid returns, low debt and room to grow.

FFBC : 34.23 (-0.55%)
KO : 83.08 (-1.39%)
JNJ : 253.85 (-1.52%)
HLNE : 82.42 (+1.68%)
RDN : 36.90 (-2.92%)
These 3 Dividend Stocks Could Boost Your Income This July

Realty Income, Johnson & Johnson, and Chevron offer yields ranging from 2.2% to 5.1% in July 2026, supported by analyst buy ratings and institutional accumulation.

CVX : 181.76 (-0.24%)
JNJ : 253.85 (-1.52%)
O : 63.77 (-0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 260.36
2nd Resistance Point 258.38
1st Resistance Point 256.11
Last Price 253.85
1st Support Level 251.86
2nd Support Level 249.88
3rd Support Level 247.61

See More

52-Week High 269.43
Last Price 253.85
Fibonacci 61.8% 225.64
Fibonacci 50% 212.11
Fibonacci 38.2% 198.59
52-Week Low 154.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.